Two drugs used to treat serious blood clots and their associated risk have been met with numerous lawsuits and mass torts as a result of undisclosed internal bleeding risks.
Zofran and Risperdal’s Off-Label Use
Many drugs are thoroughly tested by both pharmaceutical companies, helping ensure their safety during patient use.
Johnson and Johnson Lawsuits Stack Up for Numerous Products
Many drugs and medical devices are currently taking heat for unexpected side effects and complications, but one manufacturer is at the forefront of the conversation: Johnson & Johnson.
Risperdal Manufacturers Docked Again For Failure-to-Warn
A trial in the Philadelphia Court of Common Pleas reached another verdict on a case concerning Johnson & Johnson’s drug Risperdal on Friday, March 20, ruling that while the company failed to adequately warn about a major side effect, it would not award damages to plaintiff William Cirba.
When FDA-Approved Antidepressants Cause Birth Defects
Most drugs approved by the FDA go through rigorous testing to determine their safety for human use, but there’s one demographic that’s excluded: pregnant women.
Another TVM Suit Won Against Ethicon Mesh Products
The Ethicon Inc. division of Johnson & Johnson was ordered to pay $5.7 million over transvaginal mesh injuries caused by one of their devices just this month.
What Birth Defects Do Selective Serotonin Reuptake Inhibitors Cause?
Pregnancy and depression has long been under study due to the potentially adverse affects the mental illness can have on a developing baby.
Johnson & Johnson to Pay $2.5 Million in Risperdal Damages
Johnson and Johnson has to pay $2.5 million in damages to the family of a boy who developed size 46 DD breasts from taking the drug Risperdal.
4th Circuit Upholds Ethicon Division Win in TVM Appeal
Transvaginal mesh has been under strict scrutiny from the Food and Drug Administration, healthcare providers and afflicted patients thanks to a growing number of lawsuits in the past few years.
Johnson & Johnson to Pay $136 Million Risperidone Penalty
On Feb. 26, 2015, South Carolina’s Supreme Court ordered Johnson & Johnson to pay $136 million is Risperdal lawsuit penalties.